Estimating the budget impact of innovative pharmacological treatments for patients with type 2 diabetes mellitus in Italy: the case of liraglutide (GLP-1). . (2022). Epidemiology, Biostatistics, and Public Health, 12(2). https://doi.org/10.2427/11082